Cargando…
First person – Kerry Roby
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, publi...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890086/ http://dx.doi.org/10.1242/bio.059212 |
_version_ | 1784661553965957120 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, published in BiO. Kerry conducted the research described in this article while a postgraduate student in Sandra Ryeom's lab at the Perlman School of Medicine, University of Pennsylvania. He is now a Postdoc in the lab of Joseph McCarty at the MD Anderson Cancer Center, University of Texas, investigating the ‘normal’ cell populations of the tumor microenvironment, and how their manipulation promotes tumorigenesis. |
format | Online Article Text |
id | pubmed-8890086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-88900862022-03-03 First person – Kerry Roby Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, published in BiO. Kerry conducted the research described in this article while a postgraduate student in Sandra Ryeom's lab at the Perlman School of Medicine, University of Pennsylvania. He is now a Postdoc in the lab of Joseph McCarty at the MD Anderson Cancer Center, University of Texas, investigating the ‘normal’ cell populations of the tumor microenvironment, and how their manipulation promotes tumorigenesis. The Company of Biologists Ltd 2022-02-21 /pmc/articles/PMC8890086/ http://dx.doi.org/10.1242/bio.059212 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Kerry Roby |
title | First person – Kerry Roby |
title_full | First person – Kerry Roby |
title_fullStr | First person – Kerry Roby |
title_full_unstemmed | First person – Kerry Roby |
title_short | First person – Kerry Roby |
title_sort | first person – kerry roby |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890086/ http://dx.doi.org/10.1242/bio.059212 |